Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions
A poor prognosis of pancreatic ductal adenocarcinoma (PDAC) associated with chemoresistance has not changed for the past three decades. A multidisciplinary diagnosis followed by surgery and chemo(radiation)the...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Yiyin Zhang, Chao Yang, He Cheng, Zhiyao Fan, Qiuyi Huang, Yu Lu, Kun Fan, Guopei Luo, Kaizhou Jin, Zhengshi Wang, Chen Liu and Xianjun Yu Tags: Review Source Type: research